Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int J Gynecol Cancer ; 18(3): 540-5, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-17961162

RESUMEN

The cell cycle control system includes cyclins, cyclin-dependent kinases (CDK), and their inhibitors (CDK1). Extracellular regulated kinase (ERK1/2) (p44 and p42 mitogen-activated protein kinases [MAPKs]) is a component of the MAPK pathway, which is associated with cyclin D1 and CDK. It is a critical signaling system for the induction of cell proliferation, differentiation, and cell survival. The aim of this study was to investigate the usefulness of ERK2 expression as a marker of biological aggressiveness complementary to cervical intraepithelial neoplasia (CIN) grade as well as to compare its expression in preinvasive lesions with that in invasive carcinoma. Paraffin-embedded sections of 146 CIN lesions (32 CIN I, 49 CIN II, and 43 CIN III) and 22 invasive cervical carcinomas (13 squamous and 9 adenocarcinomas) were used for the standard immunohistochemical procedure with the application of the ERK2 monoclonal antibody. ERK2 staining displayed a cytoplasmic and nuclear pattern. The staining intensity was gradually increased according to the severity of the dysplastic lesions; ERK2 immunoreactivity was significantly increased in high-grade dysplastic lesions (CIN II and CIN III) and invasive carcinomas by comparison to low-grade dysplastic lesions (CIN I) (P < 0.001). When high-grade lesions were separately assessed, the differences between each one of them and CIN I retained their statistical significance: CIN II versus CIN I (P < 0.001) and CIN III versus CIN I (P < 0.001). In conclusion, our study found a direct relationship between the increasing grade of the dysplastic cervical lesions and the intensity of ERK2 staining, thus implying a role of ERK2 as an early event in cervical carcinogenesis.


Asunto(s)
Biomarcadores de Tumor/metabolismo , Proteína Quinasa 1 Activada por Mitógenos/metabolismo , Invasividad Neoplásica/patología , Displasia del Cuello del Útero/patología , Neoplasias del Cuello Uterino/patología , Adulto , Estudios de Cohortes , Intervalos de Confianza , Femenino , Regulación Neoplásica de la Expresión Génica , Humanos , Inmunohistoquímica , Persona de Mediana Edad , Proteína Quinasa 1 Activada por Mitógenos/genética , Estadificación de Neoplasias , Oportunidad Relativa , Probabilidad , Estudios Retrospectivos , Neoplasias del Cuello Uterino/genética , Neoplasias del Cuello Uterino/inmunología , Displasia del Cuello del Útero/genética , Displasia del Cuello del Útero/inmunología
2.
Biol Trace Elem Res ; 43-45: 363-70, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-7710850

RESUMEN

The trace elements antimony, bromine, cesium, cobalt, iron, rubidium, scandium, strontium and zinc were determined by instrumental neutron activation analysis in breast tissue samples with fibrocystic disease and in samples with fibroadenoma tumors. The histological lesions of each breast sample with fibrocystic disease were recorded, and a statistical analysis of the lesions in combination with the determined trace elements was carried out. The results showed that the element mean values in fibroadenoma tumors are higher than those of fibrocystic disease. Some other remarkable results of statistical examination are also presented.


Asunto(s)
Mama/metabolismo , Enfermedad Fibroquística de la Mama/metabolismo , Oligoelementos/metabolismo , Mama/química , Mama/patología , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/patología , Femenino , Fibroadenoma/metabolismo , Fibroadenoma/patología , Enfermedad Fibroquística de la Mama/patología , Humanos , Análisis de Activación de Neutrones , Estándares de Referencia , Espectrometría gamma , Spinacia oleracea/química , Oligoelementos/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA